Given a document, generate a short title of the document. The title should convey the main idea/event/topic about which the document is being written. Note that URLs in the text have been replaced with [Link].
--------
Question: Thereâs a lot going on here at Yankees camp. There is  the Great Aaron Boone Experiment . Can  he  dive from the broadcast booth to managing even though  he  has never managed before?
There is  the Great Left Field Experiment .
 Boone  pretty much solidified Greenâs bullpen future when  he  said after the game  âI think probably our preference is to eventually move  him  back [to the bullpen]  but we want to at least be in that position should something come up.â
The move back to the pen would be âpretty soon â  Boone  said.
Greenâs numbers were off the charts last season as  he  went 5-0 over 39 relief appearances in  his  first real season as a reliever. In 67 relief innings   he  posted a 1.61 ERA and struck out 100 batters. With two outs and runners in scoring position   he  held hitters to an .045 batting average.  He  still had enough left in the tank to throw 6 Â¹/â innings against the Astros in the ALCS over three games and did not allow an earned run against that mighty Houston lineup while striking out seven.
Green  26  is working on a changeup as well to get weak contact. âI just need to throw it more ââ  he  said.
Green believes  he  could maintain the same kind of velocity as a starter as  he  does out of the bullpen.
âEverybody is hoping to start  but Iâm comfortable with whatever role ââ Green said.  He  said the key is to be confident as a reliever.
Too many players worry about tomorrow. Not Green.  He âs not about to demand anything from the manager.
âThis will all play itself out ââ  he  said of the possibility of staying in the bullpen or going back to starter.  He  has a bounce-back arm that can fit any role. âIâll find a way to get it done.ââ

Answer: Yankees need to stop messing with their star reliever


Question: A few years ago he began working with Dr. Jenny Chang  medical director of the Lester and Sue Smith Breast Center at Baylor College of Medicine.
 Chang had performed a number of biopsies on breast cancer patients  both on those whose cancers were confined to the breast and on those whose cancers had metastasized to the brain.
 From those biopsies  Chang said she had identified a number of genetic pathways ways in which gene mutations affected the ability of the cancer to spread unique to patients who developed metastatic breast cancer.
 "But I had a lot of trouble with the data and trying to translate it into clinical practice " she said. She couldn't find her way out from beneath the avalanche of data.
 So she turned to Wong.
 Using his mathematical modeling  Wong sifted through Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
 One of them  a drug named sunitinib  which treats a kidney cancer called renal cell carcinoma  emerged as the best bet. Chang then tested the drug in mice  and the study showed it prevented breast cancer from spreading to the brain.
 She has already begun a Phase II clinical trial of the drug  enrolling nine patients with metastatic breast cancer  and she is looking for more.
 "The drug is very well-tolerated by patients  and so far the trial is going very well " Chang said.
 But by using an existing drug  Chang and Wong could skip the lengthy Phase I  during which a drug is checked for safety. If Chang's tests go well  sunitinib could be on the market within a few years for metastatic breast cancer.

Answer: IN OLD DRUGS RESEARCHER LOOKS FOR NEW TREATMENTS


Question: âWe work together to make sure the next 90 years empower these limitless possibilities of equality  diversity  inclusion and intersectionality â said Judd. âThatâs what this year has promised us. â
Host Jimmy Kimmel  opened with a monologue that mixed Weinstein punchlines with earnest comments about reforming gender equality in Hollywood. And of course  Kimmel â returning to the scene of the flub â dove straight into material about last yearâs infamous best-picture mix-up.
âI do want to mention  this year  when you hear your name called  donât get up right away â said  Kimmel . âGive us a minute.â
But while  Kimmel  spent a few moments on the fiasco known as Envelopegate   he  expended far more minutes frankly and soberly discussing the parade of sexual harassment allegations in the wake of the revelations regarding Weinstein. Kimimel cited the industryâs poor record for female directors and equal pay.
âWe canât let bad behavior slide anymore â said  Kimmel . âThe world is watching us.â
Gesturing to a giant statue on the stage   he  praised Oscar   himself  for keeping â his  hands where you can see themâ and for having âno penis at all.â But  Kimmel  introduced the broadcast as âa night for positivity â and cited  among other things  the box-office sensation of âBlack Panther.â
âI remember a time when the major studios didnât believe a woman or a minority could open a super hero movie â and the reason I remember that time is because it was March of last year â said  Kimmel .
With just a few minutes before the show started   Kimmel  and  his  team emerged from  his  dressing room chanting  âLetâs get it right this time!â

Answer:
Jordan Peele wins best screenplay at Oscars full of change